Literature DB >> 9342153

Acute corticosteroid myopathy in intensive care patients.

P Hanson1, A Dive, J M Brucher, M Bisteau, M Dangoisse, T Deltombe.   

Abstract

Several recent studies have attributed the occurrence of acute myopathy in intensive care unit patients to the combination of corticosteroids and neuromuscular junction blocking agents (NMBAs) used for mechanical ventilation. We present 4 patients who developed acute myopathy after administration of high doses of glucocorticoids during sedation with propofol without any NMBAs. All patients had elevated creatine kinase levels. Electrophysiological studies indicated normal motor and sensory nerve conduction velocities but reduced motor nerve response amplitudes. Needle electromyography identified abnormal spontaneous activity; motor unit potentials were polyphasic of low amplitude and short duration, characteristic of a myopathic process. Muscle biopsy demonstrated a prominent acute necrotizing myopathy in all 4 patients with a loss of thick filaments. Our observations support glucocorticoids rather than NMBAs as the main offending drug in acute corticosteroid myopathy. The predisposing factor should be the hypersensitivity of paralyzed muscles to corticosteroids regardless of the drug inducing paralysis: NMBAs or propofol.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9342153     DOI: 10.1002/(sici)1097-4598(199711)20:11<1371::aid-mus4>3.0.co;2-7

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  17 in total

1.  Glucocorticoid-induced myopathy in the intensive care unit.

Authors:  Heidi Shil Eddelien; Henrik Westy Hoffmeyer; Eva Løbner Lund; Anne Øberg Lauritsen
Journal:  BMJ Case Rep       Date:  2015-05-24

Review 2.  Steroid myopathy: some unresolved issues.

Authors:  M A Minetto; F Lanfranco; G Motta; S Allasia; E Arvat; G D'Antona
Journal:  J Endocrinol Invest       Date:  2011-05       Impact factor: 4.256

Review 3.  Diagnostic work-up in steroid myopathy.

Authors:  Marco Alessandro Minetto; Valentina D'Angelo; Emanuela Arvat; Santosh Kesari
Journal:  Endocrine       Date:  2017-11-15       Impact factor: 3.633

4.  Acute myopathy secondary to oral steroid therapy in a 49-year-old man: a case report.

Authors:  Muhammad A Khan; Eric Larson
Journal:  J Med Case Rep       Date:  2011-02-25

Review 5.  The pulmonary physician in critical care. 11: critical care management of respiratory failure resulting from COPD.

Authors:  A C Davidson
Journal:  Thorax       Date:  2002-12       Impact factor: 9.139

6.  Steroid-induced myopathy in patients intubated due to exacerbation of chronic obstructive pulmonary disease.

Authors:  Rosario Amaya-Villar; Jose Garnacho-Montero; Jose Luis García-Garmendía; Juan Madrazo-Osuna; M Carmen Garnacho-Montero; Rafael Luque; Carlos Ortiz-Leyba
Journal:  Intensive Care Med       Date:  2004-12-04       Impact factor: 17.440

7.  Electrophoretic determination of the myosin/actin ratio in the diagnosis of critical illness myopathy.

Authors:  Helena Stibler; Lars Edström; Karsten Ahlbeck; Sten Remahl; Tor Ansved
Journal:  Intensive Care Med       Date:  2003-08-12       Impact factor: 17.440

Review 8.  Toxic myopathies.

Authors:  Mamatha Pasnoor; Richard J Barohn; Mazen M Dimachkie
Journal:  Neurol Clin       Date:  2014-08       Impact factor: 3.806

9.  Two tales concerning skeletal muscle.

Authors:  David J Glass
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

Review 10.  Critical illness myopathy and polyneuropathy.

Authors:  Shawn J Bird; Mark M Rich
Journal:  Curr Neurol Neurosci Rep       Date:  2002-11       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.